行湿汤治疗急性痛风性关节炎临床观察  

Clinical Study on Xingshi Decoction in the Treatment of Acute Gouty Arthritis

作　　者：江泽平[1] 黄珍[1] 荆丽波 陈晓琳 JIANG Zeping;HUANG Zhen;JING Libo;CHEN Xiaolin(Department of Orthopedics,Foshan Hospital of Traditional Chinese Medicine,Guangdong Province,Foshan 528000,China)

机构地区：[1]佛山市中医院骨十三科,广东佛山528000

出　　处：《光明中医》2022年第10期1793-1795,共3页GUANGMING JOURNAL OF CHINESE MEDICINE

摘　　要：目的 观察行湿汤口服治疗急性痛风性关节炎的临床疗效。方法 将60例急性痛风发作患者按照随机数字表法随机分为观察组与对照组,各30例。对照组予秋水仙碱片口服联合黄水纱外敷患处,观察组在对照组基础上结合行湿汤口服,疗程均为1周;治疗前、治疗1周后分别采用视觉模拟疼痛(VAS)评分、C反应蛋白(CRP)、血尿酸(BUA),并比较2组临床疗效与安全性。结果 经1周治疗后,2组患者VAS评分、CRP、BUA较同组治疗前均明显下降(P<0.05),且观察组显著优于对照组(P<0.05);2组均未见明显不良反应。结论 行湿汤口服能进一步减轻患者疼痛、促进炎症消退及尿酸排出,值得临床推广。Objective To investigate the clinical efficacy of Xingshi decoction on acute gouty arthritis.Methods 60 patients were divided into the treatment group and the control group according to the random digital table method, with 30 cases in each. The control group was given colchicine tablets combined with external application of Shangke Huangshui gauze on the affected part, and the experimental group was given oral use of Xingshi decoction based on the treatment for the control group. The treatment for the two groups lasted 1 week. The efficacy of the two groups, the visual analogue scale(VAS), C-reactive protein(CRP), the levels of blood uric acid(BUA) and the safety was evaluated before and after treatment were compared.Results After 1 week of treatment, VAS score, CRP and BUA in 2 groups were significantly decreased compared with those before treatment(P< 0. 05), and observation group was significantly better than control group(P< 0. 05);No obvious adverse reactions were observed in 2 groups.Conclusion Xingshi decoction can can further reduce pain, promote inflammation and uric acid discharge, and is worthy of clinical promotion.

关 键 词：痹证 急性痛风性关节炎 行湿汤 中医药疗法 

分 类 号：R259[医药卫生—中西医结合]